UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type

Arteriosclerosis, thrombosis, and vascular biology, 1996-12, Vol.16 (12), p.1454-1464

1996

Volltextzugriff (PDF)

Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines

The Journal of pharmacology and experimental therapeutics, 1994-06, Vol.269 (3), p.1000

1994

Volltextzugriff (PDF)

CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption

Journal of lipid research, 1989-05, Vol.30 (5), p.681-690

1989

Volltextzugriff (PDF)

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent

Journal of medicinal chemistry, 1992-08, Vol.35 (16), p.3081-3084

1992

Volltextzugriff (PDF)

Disodium (R,R)-5[2-[[2-γ(3-chlorophenyl)-2-hydroxyethyl]-amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent β-adrenergic agonist virtually specific for β3 receptors. A promising antidiabetic and antiobesity agent

Journal of medicinal chemistry, 1992-08, Vol.35 (16), p.3081-3084

1992

Volltextzugriff (PDF)

Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetes

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (14), p.1921-1926

1999

Volltextzugriff (PDF)

Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analogs

Journal of medicinal chemistry, 1989-10, Vol.32 (10), p.2318-2325

1989

Volltextzugriff (PDF)

Cyclic amine sulfonamides as linkers in the design and synthesis of novel human beta(3) adrenergic receptor agonists

Bioorganic & medicinal chemistry letters, 2003-07, Vol.13 (13), p.2191-2194

2003

Volltextzugriff (PDF)

Antidiabetic and antiobesity effects of a highly selective β3-adrenoceptor agonist (CL 316,243)

Drug development research, 1994-06, Vol.32 (2), p.69-76

1994

Volltextzugriff (PDF)

Potential antiatherosclerotic agents. 5. An acyl-CoA:cholesterol O-acyltransferase inhibitor with hypocholesterolemic activity

Journal of medicinal chemistry, 1986-07, Vol.29 (7), p.1131-1133

1986

Volltextzugriff (PDF)

(4-Piperidin-1-yl)phenyl Amides: Potent and Selective Human β3 Agonists

Journal of medicinal chemistry, 2001-04, Vol.44 (9), p.1456-1466

2001

Volltextzugriff (PDF)

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent

Journal of medicinal chemistry, 1992-08, Vol.35 (16), p.3081-3084

1992

Volltextzugriff (PDF)

Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists

Bioorganic & medicinal chemistry, 2001-08, Vol.9 (8), p.2045-2059

2001

Volltextzugriff (PDF)

Novel substituted 4-aminomethylpiperidines as potent and selective human β-agonists. Part 1: Aryloxypropanolaminomethylpiperidines

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (20), p.2957-2961

2002

Volltextzugriff (PDF)

Novel substituted 4-aminomethylpiperidines as potent and selective human β-agonists. Part 2: Arylethanolaminomethylpiperidines

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (20), p.2963-2967

2002

Volltextzugriff (PDF)

(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists

Journal of medicinal chemistry, 2001-04, Vol.44 (9), p.1456-1466

2001

Volltextzugriff (PDF)

4-Aminopiperidine ureas as potent selective agonists of the human beta(3)-adrenergic receptor

Bioorganic & medicinal chemistry letters, 2001-12, Vol.11 (24), p.3123-3127

2001

Volltextzugriff (PDF)

Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino)benzoic acid analogs of cetaben

Journal of medicinal chemistry, 1983-10, Vol.26 (10), p.1378-1393

1983

Volltextzugriff (PDF)

Potential antiatherosclerotic agents. 4. [(Functionalized-alkyl)amino]benzoic acid analogs of cetaben

Journal of medicinal chemistry, 1983-10, Vol.26 (10), p.1411-1421

1983

Volltextzugriff (PDF)

New oxadiazolidinedione derivatives as potent and selective human beta3 agonists

Bioorganic & medicinal chemistry letters, 2001-04, Vol.11 (8), p.981-984

2001

Volltextzugriff (PDF)

Antilipolytic action of tolbutamide in isolated fat cells of the rat

Diabetes (New York, N.Y.), 1974-01, Vol.23 (1), p.51-54

1974

Volltextzugriff (PDF)

Transport of Amino Acids via the Mesenteric Lymph Duct in Rats

Experimental biology and medicine (Maywood, N.J.), 1969-03, Vol.130 (3), p.692-696

1969

Volltextzugriff (PDF)

2,4-Thiazolidinediones as potent and selective human beta3 agonists

Bioorganic & medicinal chemistry letters, 2001-03, Vol.11 (6), p.757-760

2001

Volltextzugriff (PDF)

Effect of varying K+ concentrations on phosphorylase activity, lipolysis, and cAMP levels in perfused rat heart

Experimental biology and medicine (Maywood, N.J.), 1972-10, Vol.141 (1), p.31-37

1972

Volltextzugriff (PDF)

Effect of Protein Inhibitors on Protein and Amino Acids in Mesenteric Lymph

Experimental biology and medicine (Maywood, N.J.), 1969-03, Vol.130 (3), p.697-702

1969

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Animals
(28)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Rats
(17)
Male
(16)
Pharmacology & Pharmacy
(12)
Chemistry
(11)
Humans
(10)
Chemistry, Medicinal
(9)
Adrenergic Beta-Agonists - Pharmacology
(8)
Adipose Tissue - Metabolism
(7)
Epinephrine - Pharmacology
(7)
Organic Chemistry
(7)
Structure-Activity Relationship
(7)
Biological And Medical Sciences
(6)
Exact Sciences And Technology
(6)
Medical Sciences
(6)
Methods
(6)
Mice
(6)
Pharmacology. Drug Treatments
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type

Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines

CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent

Disodium (R,R)-5[2-[[2-γ(3-chlorophenyl)-2-hydroxyethyl]-amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent β-adrenergic agonist virtually specific for β3 receptors. A promising antidiabetic and antiobesity agent

Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetes

Potential antiatherosclerotic agents. 6. Hypocholesterolemic trisubstituted urea analogs

Cyclic amine sulfonamides as linkers in the design and synthesis of novel human beta(3) adrenergic receptor agonists

Antidiabetic and antiobesity effects of a highly selective β3-adrenoceptor agonist (CL 316,243)

Potential antiatherosclerotic agents. 5. An acyl-CoA:cholesterol O-acyltransferase inhibitor with hypocholesterolemic activity

(4-Piperidin-1-yl)phenyl Amides: Potent and Selective Human β3 Agonists

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent

Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists

Novel substituted 4-aminomethylpiperidines as potent and selective human β-agonists. Part 1: Aryloxypropanolaminomethylpiperidines

Novel substituted 4-aminomethylpiperidines as potent and selective human β-agonists. Part 2: Arylethanolaminomethylpiperidines

(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists

4-Aminopiperidine ureas as potent selective agonists of the human beta(3)-adrenergic receptor

Potential antiatherosclerotic agents. 2. (Aralkylamino)- and (alkylamino)benzoic acid analogs of cetaben

Potential antiatherosclerotic agents. 4. [(Functionalized-alkyl)amino]benzoic acid analogs of cetaben

New oxadiazolidinedione derivatives as potent and selective human beta3 agonists

Antilipolytic action of tolbutamide in isolated fat cells of the rat

Transport of Amino Acids via the Mesenteric Lymph Duct in Rats

2,4-Thiazolidinediones as potent and selective human beta3 agonists

Effect of varying K+ concentrations on phosphorylase activity, lipolysis, and cAMP levels in perfused rat heart

Effect of Protein Inhibitors on Protein and Amino Acids in Mesenteric Lymph

Suchergebnisse filtern